Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.337, 2001-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Risperidone better value than olanzapine
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 261, 2000-01 ,pp. :
Access to resources
Recommend
Cost effectiveness of celecoxib, rofecoxib in OA and RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 352, 2002-01 ,pp. :
Cost effectiveness of celecoxib, rofecoxib in OA and RA
Inpharma, Vol. 1, Iss. 1327, 2002-01 ,pp. :
Celecoxib and rofecoxib equally effective in knee OA
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Fluticasone propionate better value than flunisolide in asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 245, 2000-01 ,pp. :